Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprolide Acetate for Immune Recovery Post-ASCT
NCT00275262Phase 2Terminated
- Sponsor
- Abbott Laboratories
- Start
- Feb 2006
- Primary completion
- Feb 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leuprolide in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), multiple myeloma (MM), mantle cell lymphoma (MCL), sponsored by Abbott Laboratories. Started Feb 2006; status: terminated.
02
Drugs
leuprolide
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)multiple myeloma (MM)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00275262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275262.